BeyondSpring (BYSI) Share-based Compensation (2017 - 2026)
BeyondSpring's (BYSI) quarterly Share-based Compensation came in at $570000.0 in Q2 2026, up 304.26% year-over-year from $141000.0 in Q2 2025, and up 24.18% quarter-over-quarter from $459000.0 in Q1 2026.
Powered by 
Analysis
BeyondSpring (BYSI) Share-based Compensation (2017 - 2026) Analysis & Trends
BeyondSpring has disclosed Share-based Compensation across 9 years of filings, most recently posting $570000.0 for Q2 2026.
- In Q2 2026, Share-based Compensation rose 304.26% year-over-year to $570000.0; the TTM figure through Jun 2026 stood at $1.4 million (down 16.04% YoY), while the FY2025 annual figure was $2.7 million, up 8.16% from the prior year.
- Share-based Compensation came in at $570000.0 for Q2 2026 at BeyondSpring, up from $459000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $830000.0 in Q3 2024 to a low of $141000.0 in Q2 2025.
- Average Share-based Compensation over 4 years is $410454.5, with a median of $412000.0 recorded in 2024.
- Year-over-year, Share-based Compensation sank 81.83% in 2025 and soared 304.26% in 2026.
- Over 4 years, Share-based Compensation stood at $516000.0 in 2023, then dropped by 20.16% to $412000.0 in 2024, then sank by 58.98% to $169000.0 in 2025, then jumped by 237.28% to $570000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $570000.0 in Q2 2026, $459000.0 in Q1 2026, and $169000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 249.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 277.20 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 67.26 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 19.00 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 570,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 570,000.00 |
| Mar 31, 2026 | 459,000.00 |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 238,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 830,000.00 |
| Jun 30, 2024 | 776,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Dec 31, 2023 | 516,000.00 |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 2.43 Mn |
| Mar 31, 2021 | 1.12 Mn |
| Dec 31, 2020 | 2.11 Mn |
| Sep 30, 2020 | 1.78 Mn |
| Jun 30, 2020 | 836,000.00 |
| Mar 31, 2020 | 3.47 Mn |
| Dec 31, 2019 | 351,000.00 |